Gargiulo Mario's Form 4 filing
Catalent, Inc. (CTLT) · filed Aug 26, 2022
- Accession no.
- 0001596783-22-000114
- Filed
- Aug 26, 2022
- Trade date
- Aug 24-25, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $163.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gargiulo MarioCIK 0001890248 | Officer (SVP Global Ops Biologics) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 24, 2022 | Common Stock | AGrant or awardAcquired | +3,432 | $0.00 | $0 | 7,940 | Direct | |
| Aug 25, 2022 | Common Stock | SSaleDisposed | −1,586 | $103.04 | −$163,421.44 | 6,354 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.